Document:

EX-4.1

 Exhibit 4.1 
 CONFORMED COPY 
 AMENDMENT TO RIGHTS AGREEMENT 

AMENDMENT, dated as of October 18, 2012 (“Amendment”), to Rights Agreement dated as of November 2, 2011 (the “Rights
Agreement”), between WebMD Health Corp., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York Limited Liability Company, as Rights Agent (the “Rights Agent”).
Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Rights Agreement. 
 WHEREAS, the
Company and the Rights Agent previously entered into the Rights Agreement; and 
 WHEREAS, pursuant to Section 26 of the Rights Agreement,
the Company and the Rights Agent may from time to time supplement or amend any provision of the Rights Agreement in accordance with the terms of such Section 26. 
 NOW, THEREFORE, in consideration of the foregoing premises and mutual agreements set forth in this Amendment, the parties hereby amend the Rights Agreement as follows: 

1. Section 1(a)(iii) of the Rights Agreement is hereby amended and restated in its entirety as follows: 

“(iii) any Person who has become and is such a Beneficial Owner solely because (A) of a change in the aggregate number of
shares of the Company Common Stock since the last date on which such Person acquired Beneficial Ownership of any shares of the Company Common Stock and who has not acquired Beneficial Ownership of any additional shares since the date on which such
Person became such a Beneficial Owner, (B) it acquired such Beneficial Ownership in the good faith belief that such acquisition would not (1) cause such Beneficial Ownership to be equal to or exceed 12% of the shares of the Company Common
Stock then outstanding and such Person relied in good faith in computing the percentage of its Beneficial Ownership on publicly filed reports or documents of the Company that are inaccurate or out-of-date or (2) otherwise cause a Distribution
Date or the adjustment provided for in Section 11(a)(ii) to occur or (C) of the grant of any equity compensation award (including, without limitation, an equity compensation award in the form of options, warrants, rights, restricted stock,
restricted stock units, or similar securities) by the Company to a director of the Company. Notwithstanding clause (iii)(B) of the foregoing sentence, if any Person that is not an Acquiring Person due to such clause (iii)(B) does not reduce its
percentage of Beneficial Ownership of the Company Common Stock to less than 12% (or, in the case solely of Derivative Common Shares (as such term is hereinafter defined), does not terminate the subject derivative transaction or transactions

  
 1 

 
or disposes of the subject derivative security or securities, or establish to the satisfaction of the Board of Directors of the Company that such Derivative Common Shares are not held with any
intention of changing or influencing control of the Company), in each case as promptly as practicable after notice from the Company that such Person’s Beneficial Ownership of the Company Common Stock is equal to or exceeds 12%, such Person
shall then become an Acquiring Person (and such clause (iii)(B) shall no longer apply to such Person). For purposes of this definition, the determination of whether any Person acted in “good faith” or “as promptly as practicable”
shall be conclusively determined by the Board of Directors of the Company, acting by a vote of those directors of the Company whose approval would be required to redeem the Rights under Section 23.” 

2. Section 7(a) of the Rights Agreement is hereby amended and restated in its entirety as follows: 

“(a) Prior to the earlier of (i) the Close of Business on October 31, 2014 (the “Final Expiration Date”) and
(ii) the time at which the Rights are redeemed as provided in Section 23 (the earlier of (i) and (ii) being the “Expiration Date”), the registered holder of any Rights Certificate may, subject to the provisions of
Sections 7(e) and 9(c), exercise the Rights evidenced thereby in whole or in part at any time after the Distribution Date upon surrender of the Rights Certificate, with the form of election to purchase and the certificate on the reverse side thereof
duly executed, to the Rights Agent at the office of the Rights Agent designated for such purpose, together with payment of the aggregate Purchase Price for the number of Units of Preferred Stock (or, following a Triggering Event, other securities,
cash or other assets, as the case may be) for which such surrendered Rights are then exercisable.” 
 3. Section 7(b) of the Rights
Agreement is hereby amended and restated in its entirety as follows: 
 “(b) The purchase price for each one one-thousandth
of a share (each such one one-thousandth of a share being a “Unit”) of Preferred Stock upon exercise of a Right shall be $66.29, subject to adjustment or reduction from time to time as provided in Sections 11 and 13(a) (such purchase
price, as so adjusted, being the “Purchase Price”), and shall be payable in accordance with paragraph (c) below.” 
 4. This
Amendment shall be effective as of the date hereof and, except as expressly set forth herein, the Rights Agreement shall remain in full force and effect and be otherwise unaffected hereby. 
 5. If any term, provision, covenant or restriction of this Amendment is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms,
provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated. 
 6. This Amendment shall be governed by, and construed in accordance with, the laws of the State of Delaware. 

  
 2 

 7. From and after the date hereof, all references to (i) the Rights Agreement and (ii) “this
Agreement” in the Rights Agreement, in each case, shall mean the Rights Agreement, as amended hereby. 
 8. This Amendment may be executed
(including by facsimile) in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original, but all of which taken together shall constitute one and the same
instrument. 
 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed on their behalf as of the date first above
written. 
  

			
	WEBMD HEALTH CORP.
		
	By:	 	 /s/ Douglas W. Wamsley

	Name:	 	Douglas W. Wamsley
	Title:	 	Executive Vice President
	
	AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC
		
	By:	 	 /s/ Isaac J. Kagan

	Name:	 	Isaac J. Kagan
	Title:	 	Vice President

  
 3Second Supplemental Indenture

 Exhibit 4.1 
 SECOND SUPPLEMENTAL INDENTURE 
 between 

TRIANGLE CAPITAL CORPORATION 
 and 
 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., 

as Trustee 

Dated as of October 19, 2012 
 SECOND SUPPLEMENTAL INDENTURE 
 THIS SECOND SUPPLEMENTAL INDENTURE (this
“Second Supplemental Indenture”), dated as of October 19, 2012, is between Triangle Capital Corporation, a Maryland corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., as trustee (the
“Trustee”). All capitalized terms used herein shall have the meaning set forth in the Base Indenture (as defined below). 
 RECITALS OF THE COMPANY 
 The Company and the Trustee executed and delivered an
Indenture, dated as of March 2, 2012 (the “Base Indenture” and, as supplemented by this Second Supplemental Indenture, the “Indenture”), to provide for the issuance by the Company from time to time of the Company’s
unsecured debentures, notes or other evidences of indebtedness (the “Securities”), to be issued in one or more series as provided in the Indenture. 
 The Company desires to issue and sell up to $80,500,000 aggregate principal amount of the Company’s 6.375% Senior Notes due 2022 (the “Notes”). 

The Company previously entered into the First Supplemental Indenture, dated as of March 2, 2012 (the “First Supplemental
Indenture”), which supplemented the Base Indenture. The First Supplemental Indenture is not applicable to the Notes. 

Sections 9.01(iv) and 9.01(vi) of the Base Indenture provide that without the consent of Holders of the Securities of any series issued
under the Indenture, the Company, when authorized by or pursuant to a Board Resolution, and the Trustee, at any time and from time to time, may enter into one or more indentures supplemental to the Base Indenture to (i) change or eliminate any
of the provisions of the Indenture when there is no Security Outstanding of any series created prior to the execution of the supplemental indenture that is entitled to the benefit of such provision and (ii) establish the form or terms of
Securities of any series as permitted by Section 2.01 and Section 3.01 of the Base Indenture. 
 The Company desires
to establish the form and terms of the Notes and to modify, alter, supplement and change certain provisions of the Base Indenture for the benefit of the Holders of the Notes (except as may be provided in a future supplemental indenture to the
Indenture applicable to the Notes (“Future Supplemental Indenture”)). 
 The Company has duly authorized the execution
and delivery of this Second Supplemental Indenture to provide for the issuance of the Notes and all acts and things necessary to make this Second Supplemental Indenture a valid, binding, and legal obligation of the Company and to constitute a valid
agreement of the Company, in accordance with its terms, have been done and performed. 

 NOW, THEREFORE, THIS INDENTURE WITNESSETH: 

For and in consideration of the premises and the purchase of the Notes by the Holders thereof, it is mutually agreed, for the equal and
proportionate benefit of all Holders of the Notes, as follows: 
 ARTICLE I 

TERMS OF THE NOTES 
 Section 1.01. Terms of the Notes. The following terms relating to the Notes are hereby established: 
 (a) The Notes shall constitute a series of Senior Securities having the title “6.375% Senior Notes due 2022.” The Notes shall bear a CUSIP number of 895848 307 and an ISIN number of
US8958483070. 
 (b) The aggregate principal amount of the Notes that may be initially authenticated and delivered under the
Indenture (except for Notes authenticated and delivered upon registration of, transfer of, or in exchange for, or in lieu of, other Notes pursuant to Sections 3.04, 3.05, 3.06, 9.06, 11.07 or 13.05 of the Base Indenture, and except for any
Securities which, pursuant to Section 3.03 of the Base Indenture, are deemed never to have been authenticated and delivered under the Indenture) shall be up to $80,500,000. Under a Board Resolution, Officers’ Certificate pursuant to Board
Resolutions or an indenture supplement, the Company may from time to time, without the consent of the Holders of Notes, issue additional Notes (in any such case “Additional Notes”) having the same ranking and the same interest rate,
maturity and other terms as the Notes. Any Additional Notes and the existing Notes will constitute a single series under the Indenture and all references to the relevant Notes herein shall include the Additional Notes unless the context otherwise
requires. 
 (c) The entire outstanding principal of the Notes shall be payable on December 15, 2022. 

(d) The rate at which the Notes shall bear interest shall be 6.375% per annum (the “Applicable Interest Rate”). The date
from which interest shall accrue on the Notes shall be October 19, 2012, or the most recent Interest Payment Date to which interest has been paid or provided for; the Interest Payment Dates for the Notes shall be
March 15, June 15, September 15 and December 15 of each year, commencing December 15, 2012 (if an Interest Payment Date falls on a day that is not a Business Day, then the applicable interest payment will be made
on the next succeeding Business Day and no additional interest will accrue as a result of such delayed payment); the initial interest period will be the period from and including October 19, 2012, to, but excluding, the initial Interest Payment
Date, and the subsequent interest periods will be the periods from and including an Interest Payment Date to, but excluding, the next Interest Payment Date or the Stated Maturity, as the case may be; the interest so payable, and punctually paid or
duly provided for, on any Interest Payment Date, will be paid to the Person in whose name the Note (or one or more Predecessor Notes) is registered at the close of business on the Regular Record Date for such interest, which shall be
March 1, June 1, September 1 and December 1 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. Payment of principal of (and premium, if any, on) and any such interest on the
Notes will be made at the Corporate Trust Office of the Trustee in New York, New York in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided,
however, that at the option of the Company payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register; provided, further, however, that so long as
the Notes are registered to Cede & Co., such payment will be made by wire transfer in accordance with the procedures established by The Depository Trust Company and the Trustee. Interest on the Notes will be computed on the basis of a
360-day year of twelve 30-day months. 
 (e) The Notes shall be initially issuable in global form (each such Note, a
“Global Note”). The Global Notes and the Trustee’s certificate of authentication thereon shall be substantially in the form of Exhibit A to this Second Supplemental Indenture. Each Global Note shall represent the outstanding
Notes as shall be specified therein and each shall provide that it shall represent the aggregate amount of outstanding Notes from time to time endorsed thereon and that the aggregate amount of outstanding Notes represented thereby may from time to
time be reduced or increased, as appropriate, to reflect exchanges and redemptions. Any endorsement of a Global Note to reflect the amount of any increase or decrease in the amount of outstanding Notes represented thereby shall be made by the
Trustee or the Security Registrar, in accordance with Sections 2.03 and 3.05 of the Base Indenture. 

  
 - 2 -

 (f) The depositary for such Global Notes (the “Depositary”) shall be The
Depository Trust Company, New York, New York. The Security Registrar with respect to the Global Notes shall be the Trustee. 

(g) The Notes shall be defeasible pursuant to Section 14.02 or Section 14.03 of the Base Indenture. Covenant defeasance
contained in Section 14.03 of the Base Indenture shall apply to the covenants contained in Sections 10.06, 10.08 and 10.09 of the Indenture. 
 (h) The Notes shall be redeemable pursuant to Section 11.01 of the Base Indenture and as follows: 
 (i) The Notes will be redeemable in whole or in part at any time or from time to time, at the option of the Company, on or after December 15, 2015, at a redemption price equal to 100% of the
outstanding principal amount thereof plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to, but excluding, the date fixed for redemption. 

(ii) Notice of redemption shall be given in writing and mailed, first-class postage prepaid or by overnight courier guaranteeing
next-day delivery, to each Holder of the Notes to be redeemed, not less than thirty (30) nor more than sixty (60) days prior to the Redemption Date, at the Holder’s address appearing in the Security Register. All notices of redemption
shall contain the information set forth in Section 11.04 of the Base Indenture. 
 (iii) Any exercise of the
Company’s option to redeem the Notes will be done in compliance with the Investment Company Act, to the extent applicable. 
 (iv) If the Company elects to redeem only a portion of the Notes, the Trustee will determine the method for selecting the particular Notes to be redeemed, in accordance with the Investment Company Act, to
the extent applicable. 
 (v) Unless the Company defaults in payment of the Redemption Price, on and after the Redemption Date,
interest will cease to accrue on the Notes called for redemption hereunder. 
 (i) The Notes shall not be subject to any sinking
fund pursuant to Section 12.01 of the Base Indenture. 
 (j) The Notes shall be issuable in denominations of $25 and
integral multiples of $25 in excess thereof. 
 (k) Holders of the Notes will not have the option to have the Notes repaid prior
to the Stated Maturity. 
 (l) The Notes are hereby designated as “Senior Securities” under the Indenture. 

ARTICLE II 

DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 
 Section 2.01. Except as may be provided in a Future Supplemental Indenture, for the benefit of the Holders of the Notes but no other series of Securities under the Indenture, whether now or hereafter
issued and Outstanding, Article I of the Base Indenture shall be amended by adding the following defined terms to Section 1.01 in appropriate alphabetical sequence, as follows: 

“‘Exchange Act’ means the Securities Exchange Act of 1934, as amended, and any statute successor thereto.”

  
 - 3 -

 “‘GAAP’ means generally accepted accounting principles in the United
States set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants, the opinions and pronouncements of the Public Company Accounting Oversight Board and the statements and
pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as have been approved by a significant segment of the accounting profession in the United States, which are in effect from time to
time.” 
 “‘Investment Company Act’ means the Investment Company Act of 1940, as amended, and the
rules, regulations and interpretations promulgated thereunder, to the extent applicable, and any statute successor thereto.” 
 ARTICLE III 
 REMEDIES 

Section 3.01. Except as may be provided in a Future Supplemental Indenture, for the benefit of the Holders of the Notes but no other
series of Securities under the Indenture, whether now or hereafter issued and Outstanding, Section 5.01 of the Base Indenture shall be amended by replacing clause (ii) thereof with the following: 

“(ii) default in the payment of the principal of (or premium, if any on) any Note when it becomes due and payable at
its Maturity; or”; and 
 ARTICLE IV 
 COVENANTS 
 Section 4.01. Except as may be provided in a Future Supplemental
Indenture, for the benefit of the Holders of the Notes but no other series of Securities under the Indenture, whether now or hereafter issued and Outstanding, Article X of the Base Indenture shall be amended by adding the following new Sections
10.08 and 10.09 thereto, each as set forth below: 
 “Section 10.08 Section 18(a)(1) of the
Investment Company Act. 
 The Company hereby agrees that for the period of time during which Notes are
Outstanding, the Company will not violate, whether or not it is subject to, Section 18(a)(1) as modified by Section 61(a)(1) of the Investment Company Act or any successor provisions thereto of the Investment Company Act, but giving
effect, in either case, to any exemptive relief granted to the Company by the Securities and Exchange Commission.” 
 “Section 10.09 Commission Reports and Reports to Holders. 
 If, at any time, the Company is not subject to the reporting requirements of Sections 13 or 15(d) of the Exchange Act to file any periodic reports with the Securities and Exchange Commission, the Company
agrees to furnish to the Holders of Notes and the Trustee for the period of time during which the Notes are Outstanding: (i) within 90 days after the end of the each fiscal year of the Company, audited annual consolidated financial statements
of the Company and (ii) within 45 days after the end of each fiscal quarter of the Company (other than the Company’s fourth fiscal quarter), unaudited interim consolidated financial statements of the Company. All such financial statements
shall be prepared, in all material respects, in accordance with GAAP.” 

  
 - 4 -

 ARTICLE V 
 MISCELLANEOUS 
 Section 5.01. This Second Supplemental Indenture and the
Notes shall be governed by and construed in accordance with the laws of the State of New York, without regard to principles of conflicts of laws that would cause the application of laws of another jurisdiction. This Second Supplemental Indenture is
subject to the provisions of the Trust Indenture Act that are required to be part of the Indenture and shall, to the extent applicable, be governed by such provisions. 
 Section 5.02. In case any provision in this Second Supplemental Indenture or in the Notes shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining
provisions shall not in any way be affected or impaired thereby. 
 Section 5.03. This Second Supplemental Indenture may be
executed in any number of counterparts, each of which will be an original, but such counterparts will together constitute but one and the same Second Supplemental Indenture. The exchange of copies of this Second Supplemental Indenture and of
signature pages by facsimile, .pdf transmission, email or other electronic means shall constitute effective execution and delivery of this Second Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile,
..pdf transmission, email or other electronic means shall be deemed to be their original signatures for all purposes. 

Section 5.04. The Base Indenture, as supplemented and amended by this Second Supplemental Indenture, is in all respects ratified and
confirmed, and the Base Indenture and this Second Supplemental Indenture shall be read, taken and construed as one and the same instrument with respect to the Notes. All provisions included in this Second Supplemental Indenture supersede any
conflicting provisions included in the Base Indenture with respect to the Notes, unless not permitted by law. The Trustee accepts the trusts created by the Base Indenture, as supplemented by this Second Supplemental Indenture, and agrees to perform
the same upon the terms and conditions of the Base Indenture, as supplemented by this Second Supplemental Indenture. 

Section 5.05. The provisions of this Second Supplemental Indenture shall become effective as of the date hereof. 

Section 5.06. Notwithstanding anything else to the contrary herein, the terms and provisions of this Second Supplemental Indenture
shall apply only to the Notes and shall not apply to any other series of Securities under the Indenture and this Second Supplemental Indenture shall not and does not otherwise affect, modify, alter, supplement or change the terms and provisions of
any other series of Securities under the Indenture, whether now or hereafter issued and Outstanding. 
 Section 5.07. The
recitals contained herein and in the Notes shall be taken as the statements of the Company, and the Trustee assumes no responsibility for their correctness. The Trustee makes no representations as to the validity or sufficiency of this Second
Supplemental Indenture, the Notes or any Additional Notes, except that the Trustee represents that it is duly authorized to execute and deliver this Second Supplemental Indenture, authenticate the Notes and any Additional Notes and perform its
obligations hereunder. The Trustee shall not be accountable for the use or application by the Company of the Notes or any Additional Notes or the proceeds thereof. 

  
 - 5 -

 IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be
duly executed as of the date first above written. 
  

			
	TRIANGLE CAPITAL CORPORATION
		
	By:	 	 /s/ Steven C. Lilly

	Name: Steven C. Lilly
	Title: Chief Financial Officer, Secretary and Treasurer
	
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	 /s/ Lawrence M. Kusch

	Name: Lawrence M. Kusch
	Title: Vice President

 [Signature page to Second Supplemental Indenture] 

 Exhibit A – Form of Global Note 

This Security is a Global Note within the meaning of the Indenture hereinafter referred to and is registered in the name of The Depository Trust
Company or a nominee thereof. This Security may not be exchanged in whole or in part for a Security registered, and no transfer of this Security in whole or in part may be registered, in the name of any Person other than The Depository Trust Company
or a nominee thereof, except in the limited circumstances described in the Indenture. 
 Unless this certificate is presented by an
authorized representative of The Depository Trust Company to the issuer or its agent for registration of transfer, exchange or payment and such certificate issued in exchange for this certificate is registered in the name of Cede & Co., or
such other name as requested by an authorized representative of The Depository Trust Company, any transfer, pledge or other use hereof for value or otherwise by or to any person is wrongful, as the registered owner hereof, Cede & Co., has
an interest herein. 
 Triangle Capital Corporation 

 

			
	No.    	  	$            
		  	 CUSIP No. 895848 307

ISIN No. US8958483070

 6.375% Senior Notes due 2022 
 Triangle Capital Corporation, a corporation duly organized and existing under the laws of Maryland (herein called the “Company”, which term includes any successor Person under the Indenture
hereinafter referred to), for value received, hereby promises to pay to Cede & Co., or registered assigns, the principal sum of                 U.S. DOLLARS
(U.S. $             ) on December 15, 2022, and to pay interest thereon from October 19, 2012 or from the most recent Interest Payment Date to which interest has been paid or duly
provided for, quarterly on March 15, June 15, September 15 and December 15 in each year, commencing December 15, 2012, at the rate of 6.375% per annum, until the principal hereof is paid or made available for
payment. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security is registered at the close of business on the Regular
Record Date for such interest, which shall be March 1, June 1, September 1 and December 1 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. Any such interest not so
punctually paid or duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security is registered at the close of business on a Special Record Date for
the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner
not inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. This Security may be
issued as part of a series. 
 Payment of the principal of (and premium, if any, on) and any such interest on this Security will
be made at the Corporate Trust Office of the Trustee in New York, New York in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private
debts; provided, however, that at the option of the Company payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register; provided,
further, however, that so long as the Notes are registered to Cede & Co., such payment will be made by wire transfer in accordance with the procedures established by The Depository Trust Company and the Trustee. 

Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for
all purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has been
executed by the Trustee referred to on the reverse hereof by manual signature, this Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

  
 Exhibit A-1

 IN WITNESS WHEREOF, the Company has caused this
instrument to be duly executed. 
 Dated: 
  

			
	TRIANGLE CAPITAL CORPORATION
		
	By:	 	  

		 	 Name:

Title:

  
 Exhibit A-2

 This is one of the Securities of the series designated therein referred to in the
within-mentioned Indenture. 
 Dated:
  

			
	 THE BANK OF NEW YORK MELLON TRUST
 COMPANY, N.A.
 as Trustee

		
	By:	 	  

		 	Authorized Signatory

  
 Exhibit A-3

 Triangle Capital Corporation 

6.375% Senior Notes due 2022 
 This Security is one of a duly authorized issue of Senior Securities of the Company (herein called the “Securities”), issued and to be issued in one or more series under an Indenture, dated as
of March 2, 2012 (herein called the “Base Indenture”, which term shall have the meaning assigned to it in such instrument), between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (herein called the
“Trustee”, which term includes any successor trustee under the Base Indenture), and reference is hereby made to the Base Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the
Company, the Trustee, and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered, as supplemented by the Second Supplemental Indenture relating to the Securities, dated
October 19, 2012, by and between the Company and the Trustee (herein called the “Second Supplemental Indenture,” the Second Supplemental Indenture and the Base Indenture collectively are herein called the “Indenture”). In
the event of any conflict between the Base Indenture and the Second Supplemental Indenture, the Second Supplemental Indenture shall govern and control. 
 This Security is one of the series designated on the face hereof, initially limited in aggregate principal amount to $80,500,000. Under a Board Resolution, Officers’ Certificate pursuant to
Board Resolutions or an indenture supplement, the Company may from time to time, without the consent of the Holders of Securities, issue additional Securities of this series (in any such case “Additional Securities”) having the same
ranking and the same interest rate, maturity and other terms as the Securities. Any Additional Securities and the existing Securities will constitute a single series under the Indenture and all references to the relevant Securities herein shall
include the Additional Securities unless the context otherwise requires. The aggregate amount of outstanding Securities represented hereby may from time to time be reduced or increased, as appropriate, to reflect exchanges and redemptions.

 The Securities of this series are subject to redemption in whole or in part at any time or from time to time, at the option
of the Company, on or after December 15, 2015, at a redemption price equal to 100% of the outstanding principal amount thereof plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to
the date fixed for redemption. 
 Notice of redemption shall be given in writing and mailed, first-class postage prepaid or by
overnight courier guaranteeing next-day delivery, to each Holder of the Securities to be redeemed, not less than thirty (30) nor more than sixty (60) days prior to the Redemption Date, at the Holder’s address appearing in the Security
Register. All notices of redemption shall contain the information set forth in Section 11.04 of the Base Indenture. 
 Any
exercise of the Company’s option to redeem the Securities will be done in compliance with the Investment Company Act, to the extent applicable. 
 If the Company elects to redeem only a portion of the Securities, the Trustee will determine the method for selecting the particular Securities to be redeemed, in accordance with the Indenture. In the
event of redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof. 

Unless the Company defaults in payment of the Redemption Price, on and after the Redemption Date, interest will cease to accrue on the
Notes called for redemption. 
 Holders of Securities do not have the option to have the Securities repaid prior to
December 15, 2015. 

  
 Exhibit A-4

 The Indenture contains provisions for defeasance at any time of the entire indebtedness of
this Security or certain restrictive covenants and Events of Default with respect to this Security, in each case upon compliance with certain conditions set forth in the Indenture. 

If an Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this
series may be declared due and payable in the manner and with the effect provided in the Indenture. 
 The Indenture permits,
with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the
Company and the Trustee with the consent of the Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of
specified percentages in principal amount of the Securities of each series at the time Outstanding, on behalf of the Holders of all Securities of such series, to waive compliance by the Company with certain provisions of the Indenture and certain
past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the
registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Security. 
 As provided in and subject to the provisions of the Indenture, the Holder of this Security shall not have the right to institute any proceeding with respect to the Indenture or for the appointment of a
receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a continuing Event of Default with respect to the Securities of this series, the Holders of not less than 25% in
principal amount of the Securities of this series at the time Outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of Default as Trustee and offered the Trustee reasonable indemnity against the
costs, expenses and liabilities to be incurred in compliance with such request, and the Trustee shall not have received from the Holders of a majority in principal amount of Securities of this series at the time Outstanding a direction inconsistent
with such request, and shall have failed to institute any such proceeding, for sixty (60) days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Security for
the enforcement of any payment of principal hereof or any premium or interest hereon on or after the respective due dates expressed herein. 
 No reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of
and any premium and interest on this Security at the times, place and rate, and in the coin or currency, herein prescribed. 

As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the
Security Register, upon surrender of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on this Security are payable, duly endorsed by, or accompanied by
a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Securities of this series and of like
tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 
 The Securities of this series are issuable only in registered form without coupons in denominations of $25 and any integral multiples of $25 in excess thereof. As provided in the Indenture and subject to
certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering
the same. 
 No service charge shall be made for any such registration of transfer or exchange, but the Company or Trustee may
require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

  
 Exhibit A-5

 Prior to due presentment of this Security for registration of transfer, the Company, the
Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Company, the Trustee nor any such agent
shall be affected by notice to the contrary. 
 All terms used in this Security which are defined in the Indenture shall have
the meanings assigned to them in the Indenture. 
 The Indenture and this Security shall be governed by and construed in
accordance with the laws of the State of New York, without regard to principles of conflicts of laws. 

  
 Exhibit A-6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}]]